Literature DB >> 25991416

Soluble Epoxide Hydrolase in Hydrocephalus, Cerebral Edema, and Vascular Inflammation After Subarachnoid Hemorrhage.

Dominic A Siler1, Yosef A Berlow1, Ayaka Kukino1, Catherine M Davis1, Jonathan W Nelson1, Marjorie R Grafe1, Hirohisa Ono1, Justin S Cetas1, Martin Pike1, Nabil J Alkayed2.   

Abstract

BACKGROUND AND
PURPOSE: Acute communicating hydrocephalus and cerebral edema are common and serious complications of subarachnoid hemorrhage (SAH), whose causes are poorly understood. Using a mouse model of SAH, we determined whether soluble epoxide hydrolase (sEH) gene deletion protects against SAH-induced hydrocephalus and edema by increasing levels of vasoprotective eicosanoids and suppressing vascular inflammation.
METHODS: SAH was induced via endovascular puncture in wild-type and sEH knockout mice. Hydrocephalus and tissue edema were assessed by T2-weighted magnetic resonance imaging. Endothelial activation was assessed in vivo using T2*-weighted magnetic resonance imaging after intravenous administration of iron oxide particles linked to anti-vascular cell adhesion molecule-1 antibody 24 hours after SAH. Behavioral outcome was assessed at 96 hours after SAH with the open field and accelerated rotarod tests.
RESULTS: SAH induced an acute sustained communicating hydrocephalus within 6 hours of endovascular puncture in both wild-type and sEH knockout mice. This was followed by tissue edema, which peaked at 24 hours after SAH and was limited to white matter fiber tracts. sEH knockout mice had reduced edema, less vascular cell adhesion molecule-1 uptake, and improved outcome compared with wild-type mice.
CONCLUSIONS: Genetic deletion of sEH reduces vascular inflammation and edema and improves outcome after SAH. sEH inhibition may serve as a novel therapy for SAH.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  communicating hydrocephalus; edema; subarachnoid hemorrhage; vascular cell adhesion molecule-1

Mesh:

Substances:

Year:  2015        PMID: 25991416      PMCID: PMC4480190          DOI: 10.1161/STROKEAHA.114.008560

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  40 in total

1.  Detection of soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage.

Authors:  Mehmet Yasar Kaynar; Taner Tanriverdi; Ali Metin Kafadar; Tibet Kacira; Hafize Uzun; Seval Aydin; Koray Gumustas; Ahmet Dirican; Cengiz Kuday
Journal:  J Neurosurg       Date:  2004-12       Impact factor: 5.115

Review 2.  Immunologic privilege in the central nervous system and the blood-brain barrier.

Authors:  Leslie L Muldoon; Jorge I Alvarez; David J Begley; Ruben J Boado; Gregory J Del Zoppo; Nancy D Doolittle; Britta Engelhardt; John M Hallenbeck; Russell R Lonser; John R Ohlfest; Alexandre Prat; Maurizio Scarpa; Richard J Smeyne; Lester R Drewes; Edward A Neuwelt
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-17       Impact factor: 6.200

3.  Soluble epoxide hydrolase is a therapeutic target for acute inflammation.

Authors:  Kara R Schmelzer; Lukas Kubala; John W Newman; In-Hae Kim; Jason P Eiserich; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-30       Impact factor: 11.205

4.  Ultra-sensitive molecular MRI of vascular cell adhesion molecule-1 reveals a dynamic inflammatory penumbra after strokes.

Authors:  Maxime Gauberti; Axel Montagne; Oscar A Marcos-Contreras; Audrey Le Béhot; Eric Maubert; Denis Vivien
Journal:  Stroke       Date:  2013-06-06       Impact factor: 7.914

5.  Incidence of ventricular shunt placement for hydrocephalus with clipping versus coiling for ruptured and unruptured cerebral aneurysms in the Nationwide Inpatient Sample database: 2002 to 2007.

Authors:  Brian L Hoh; Dominic T Kleinhenz; Yueh-Yun Chi; J Mocco; Fred G Barker
Journal:  World Neurosurg       Date:  2011-12       Impact factor: 2.104

6.  Extent of acute hydrocephalus after subarachnoid hemorrhage as a risk factor for poor functional outcome.

Authors:  Stefan Dupont; Alejandro A Rabinstein
Journal:  Neurol Res       Date:  2013-03       Impact factor: 2.448

7.  Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.

Authors:  Arzu Ulu; Todd R Harris; Christophe Morisseau; Christina Miyabe; Hiromi Inoue; Gertrud Schuster; Hua Dong; Ana-Maria Iosif; Jun-Yan Liu; Robert H Weiss; Nipavan Chiamvimonvat; John D Imig; Bruce D Hammock
Journal:  J Cardiovasc Pharmacol       Date:  2013-09       Impact factor: 3.105

8.  Real time estimation of brain water content in comatose patients.

Authors:  Sang-Bae Ko; H Alex Choi; Gunjan Parikh; J Michael Schmidt; Kiwon Lee; Neeraj Badjatia; Jan Claassen; E Sander Connolly; Stephan A Mayer
Journal:  Ann Neurol       Date:  2012-08-22       Impact factor: 10.422

9.  Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury.

Authors:  Ines P Koerner; Rachel Jacks; Andrea E DeBarber; Dennis Koop; Peizhong Mao; David F Grant; Nabil J Alkayed
Journal:  J Neurosci       Date:  2007-04-25       Impact factor: 6.167

10.  Accelerated progression of kaolin-induced hydrocephalus in aquaporin-4-deficient mice.

Authors:  Orin Bloch; Kurtis I Auguste; Geoffrey T Manley; A S Verkman
Journal:  J Cereb Blood Flow Metab       Date:  2006-03-22       Impact factor: 6.200

View more
  18 in total

Review 1.  Role of epoxy-fatty acids and epoxide hydrolases in the pathology of neuro-inflammation.

Authors:  Sean D Kodani; Christophe Morisseau
Journal:  Biochimie       Date:  2019-02-01       Impact factor: 4.079

Review 2.  Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders.

Authors:  Sydney Zarriello; Julian P Tuazon; Sydney Corey; Samantha Schimmel; Mira Rajani; Anna Gorsky; Diego Incontri; Bruce D Hammock; Cesar V Borlongan
Journal:  Prog Neurobiol       Date:  2018-11-14       Impact factor: 11.685

Review 3.  Neurobehavioral testing in subarachnoid hemorrhage: A review of methods and current findings in rodents.

Authors:  Nefize Turan; Brandon A Miller; Robert A Heider; Maheen Nadeem; Iqbal Sayeed; Donald G Stein; Gustavo Pradilla
Journal:  J Cereb Blood Flow Metab       Date:  2016-10-01       Impact factor: 6.200

4.  A Systematic and Meta-Analysis of Mortality in Experimental Mouse Models Analyzing Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.

Authors:  Marcel A Kamp; Jasper H van Lieshout; Maxine Dibué-Adjei; Jasmin K Weber; Toni Schneider; Tanja Restin; Igor Fischer; Hans-Jakob Steiger
Journal:  Transl Stroke Res       Date:  2017-01-30       Impact factor: 6.829

Review 5.  Mechanisms of Global Cerebral Edema Formation in Aneurysmal Subarachnoid Hemorrhage.

Authors:  Erik G Hayman; Aaron Wessell; Volodymyr Gerzanich; Kevin N Sheth; J Marc Simard
Journal:  Neurocrit Care       Date:  2017-04       Impact factor: 3.210

6.  Age-dependent cognitive impairment, hydrocephalus and leukocyte infiltration in transgenic mice with endothelial expression of human EPHX2.

Authors:  Catherine M Davis; Wenri H Zhang; Thierno M Bah; Natalie E Roese; Elyse M Allen; Philberta Leung; Sydney J Boutros; Tessa Marzulla; Esha Patel; Xiao Nie; Farah N Alkayed; Justin H Huang; Michael A Jensen; Jacob Raber; Martin M Pike; Nabil J Alkayed
Journal:  NPJ Aging       Date:  2022-07-05

Review 7.  Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke.

Authors:  Hui Huang; Mohamed Al-Shabrawey; Mong-Heng Wang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-12-30       Impact factor: 3.072

Review 8.  Cytochrome P450 eicosanoids in cerebrovascular function and disease.

Authors:  Catherine M Davis; Xuehong Liu; Nabil J Alkayed
Journal:  Pharmacol Ther       Date:  2017-05-18       Impact factor: 12.310

9.  A Double-Blind, Randomized, Placebo-Controlled Trial of Soluble Epoxide Hydrolase Inhibition in Patients with Aneurysmal Subarachnoid Hemorrhage.

Authors:  Ross P Martini; Dominic Siler; Justin Cetas; Nabil J Alkayed; Elyse Allen; Miriam M Treggiari
Journal:  Neurocrit Care       Date:  2021-12-06       Impact factor: 3.210

10.  CYP450-derived oxylipins mediate inflammatory resolution.

Authors:  Derek W Gilroy; Matthew L Edin; Roel P H De Maeyer; Jonas Bystrom; Justine Newson; Fred B Lih; Melanie Stables; Darryl C Zeldin; David Bishop-Bailey
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.